ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Orchard Therapeutics North America

Official 2024 U.S. DOL Form 5500 summary for Orchard Therapeutics North America (Orchard Therapeutics 401(k) Plan · EIN 81-2354450 · PN 001): $7,919 net assets, 0 active participants, and $11.40 per $10,000 (11.40 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorOrchard Therapeutics North America
Filing IdentifierOrchard Therapeutics 401(k) Plan · EIN 81-2354450 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$1M-$5M
Plan Net Assets (2024)$7,919
Active Participants0
Direct Admin Fee Rate$11.40 per $10,000 (11.40 bps)
Cohort Peer Median$63.02 per $10,000 (63.02 bps)
Primary Recordkeeper / ProviderT. Rowe Price
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI